(Q34593849)

3 August 2017

1 reference

title

Superficial bladder cancer T1G3: the choice of treatment (English)

1 reference

3 August 2017

1 reference

Borkowski A

1

1 reference

3 August 2017

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

89

1 reference

3 August 2017

6

1 reference

3 August 2017

623-627

1 reference

The management of superficial bladder cancer

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

Preventing progression and improving survival with BCG maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.02696.X

10.1046/J.1464-410X.2002.02696.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11942979